Highest-scoring questions on the site.
Setup, so nobody has to ask: Wuxi · the Netherlands. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
Conditions: a stablecoin transfer · Ireland. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
The specifics, since they change the answer: identity confirmation by mass spectrometry · ecnoglutide. I am trying to choose between two options that are usually…
What I have: 97.1% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The particulars: 96.4% · PeptideMeter · 98.8%. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
What I have: a 0.3 mL insulin syringe · 2.5 mg · 10 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are…
The particulars: fibrillation · minus 80 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles…
What I have: oral semaglutide · ten days. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.…
Numbers first: cagrilintide · 2–8 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
The lane and the lead time matter as much as the material for what I am doing. I have the document in front of me and I can read the numbers. What I cannot do is…
Concretely: SSA · ecnoglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
Details up front: hydrolysis · minus 20 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
Details up front: 25 units · 4 mg/mL. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked. Assume no…
Stated plainly: WWB · WuXi TIDES. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is reproducibility,…
What I have: a GLP-1 receptor agonist · cagrilintide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Numbers first: a GLP-1 receptor agonist · 40 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is…
Numbers first: cagrilintide · 25 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I would rather over-plan the first cycle and simplify…
The particulars: 95.2% · PeptideMeter · 98.8% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
What I am working with: QYB · HJ · Sweden. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
Stated plainly: cagrilintide · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The specifics, since they change the answer: 50 mg · 2.5 mL · phosphate-buffered diluent · orforglipron. I am at the decision point and I would rather think it…
The case in front of me: semaglutide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…